Zosano Pharma to Report Fourth Quarter and 2015 Financial Results and to Provide a Corporate Update
Mar 21, 2016 12:30 pm UTC| Business
FREMONT, Calif., March 21, 2016 -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the fourth quarter and full year 2015 on Tuesday, March 29, 2016. Zosano will host...
WisdomTree ETFs Declare Distributions
Mar 21, 2016 12:30 pm UTC| Business
NEW YORK, March 21, 2016 -- WisdomTree (NASDAQ:WETF) today announced that WisdomTree declared distributions for the following WisdomTree ETFs. Rates are listed below: TickerFund NameEx-dateRecord DatePay DateOrdinary...
Ultragenyx Appoints Lars Ekman, M.D., Ph.D., to Board of Directors
Mar 21, 2016 12:30 pm UTC| Business
NOVATO, Calif., March 21, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the appointment...
Insight Recognized with Five Cisco Partner Summit Awards
Mar 21, 2016 12:30 pm UTC| Business
TEMPE, Ariz., March 21, 2016 -- Insight (NASDAQ:NSIT) was recognized with five Cisco Partner Summit 2016 Awards at Cisco’s annual Partner Summit in San Diego. Insight received the following awards: US-Architectural...
Allied Motion Names Kevin McNicholas as Vice President of Sales
Mar 21, 2016 12:30 pm UTC| Business
AMHERST, N.Y., March 21, 2016 -- Allied Motion Technologies Inc. (NASDAQ:AMOT), a global designer and manufacturer of motion control products, announced that Kevin McNicholas has joined the Company as Vice President of...
CombiMatrix Prices $8.0 Million Underwritten Public Offering
Mar 21, 2016 12:12 pm UTC| Business
IRVINE, Calif., March 21, 2016 -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation...
Mar 21, 2016 12:05 pm UTC| Business
NEWARK, Calif., March 21, 2016 -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous system diseases, announced today that it...